Evaluation of Malignant Hyperthermia Features in Patients with Pathogenic or Likely Pathogenic RYR1 Variants Disclosed through a Population Genomic Screening Program von Yu, Kristen D, Betts, Megan N, Urban, Gretchen M, Schwartz, Marci L B, Robinson, Tanisha O, Moyer, Robert J, Taddonio, Scott W, Vasudevan, Anasuya, Johns, Alicia, Sturm, Amy C, Kelly, Melissa A, Williams, Marc S, Poler, S Mark, Buchanan, Adam H

Volltext

PRESSURE REDISTRIBUTION SYSTEM AND METHODS OF USING SAME von BEDNARZ, III, Edward T, MOYER, JR., Robert W, PILLAI, Amal, WERNER, Autumn L, BEDNARZ, Heather T, AGUILAR, Matthew T, UGWU, Jason E

Volltext bestellen

Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor von Daigle, Scott R., Olhava, Edward J., Therkelsen, Carly A., Majer, Christina R., Sneeringer, Christopher J., Song, Jeffrey, Johnston, L. Danielle, Scott, Margaret Porter, Smith, Jesse J., Xiao, Yonghong, Jin, Lei, Kuntz, Kevin W., Chesworth, Richard, Moyer, Mikel P., Bernt, Kathrin M., Tseng, Jen-Chieh, Kung, Andrew L., Armstrong, Scott A., Copeland, Robert A., Richon, Victoria M., Pollock, Roy M.

Volltext

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia von Daigle, Scott R., Olhava, Edward J., Therkelsen, Carly A., Basavapathruni, Aravind, Jin, Lei, Boriack-Sjodin, P. Ann, Allain, Christina J., Klaus, Christine R., Raimondi, Alejandra, Scott, Margaret Porter, Waters, Nigel J., Chesworth, Richard, Moyer, Mikel P., Copeland, Robert A., Richon, Victoria M., Pollock, Roy M.

Volltext

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells von Knutson, Sarah K, Wigle, Tim J, Warholic, Natalie M, Sneeringer, Christopher J, Allain, Christina J, Klaus, Christine R, Sacks, Joelle D, Raimondi, Alejandra, Majer, Christina R, Song, Jeffrey, Scott, Margaret Porter, Jin, Lei, Smith, Jesse J, Olhava, Edward J, Chesworth, Richard, Moyer, Mikel P, Richon, Victoria M, Copeland, Robert A, Keilhack, Heike, Pollock, Roy M, Kuntz, Kevin W

Volltext

Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma von Knutson, Sarah K, Kawano, Satoshi, Minoshima, Yukinori, Warholic, Natalie M, Huang, Kuan-Chun, Xiao, Yonghong, Kadowaki, Tadashi, Uesugi, Mai, Kuznetsov, Galina, Kumar, Namita, Wigle, Tim J, Klaus, Christine R, Allain, Christina J, Raimondi, Alejandra, Waters, Nigel J, Smith, Jesse J, Porter-Scott, Margaret, Chesworth, Richard, Moyer, Mikel P, Copeland, Robert A, Richon, Victoria M, Uenaka, Toshimitsu, Pollock, Roy M, Kuntz, Kevin W, Yokoi, Akira, Keilhack, Heike

Volltext

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2 von Knutson, Sarah K., Warholic, Natalie M., Wigle, Tim J., Klaus, Christine R., Allain, Christina J., Raimondi, Alejandra, Scott, Margaret Porter, Chesworth, Richard, Moyer, Mikel P., Copeland, Robert A., Richon, Victoria M., Pollock, Roy M., Kuntz, Kevin W., Keilhack, Heike

Volltext

The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat von Kuntz, Kevin W, Campbell, John E, Keilhack, Heike, Pollock, Roy M, Knutson, Sarah K, Porter-Scott, Margaret, Richon, Victoria M, Sneeringer, Chris J, Wigle, Tim J, Allain, Christina J, Majer, Christina R, Moyer, Mikel P, Copeland, Robert A, Chesworth, Richard

Volltext

Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas von Knutson, Sarah K, Warholic, Natalie M, Johnston, L Danielle, Klaus, Christine R, Wigle, Tim J, Iwanowicz, Dorothy, Littlefield, Bruce A, Porter-Scott, Margaret, Smith, Jesse J, Moyer, Mikel P, Copeland, Robert A, Pollock, Roy M, Kuntz, Kevin W, Raimondi, Alejandra, Keilhack, Heike

Volltext

Atomically engineered ferroic layers yield a room-temperature magnetoelectric multiferroic von Mundy, Julia A., Brooks, Charles M., Holtz, Megan E., Moyer, Jarrett A., Das, Hena, Rébola, Alejandro F., Heron, John T., Clarkson, James D., Disseler, Steven M., Liu, Zhiqi, Farhan, Alan, Held, Rainer, Hovden, Robert, Padgett, Elliot, Mao, Qingyun, Paik, Hanjong, Misra, Rajiv, Kourkoutis, Lena F., Arenholz, Elke, Scholl, Andreas, Borchers, Julie A., Ratcliff, William D., Ramesh, Ramamoorthy, Fennie, Craig J., Schiffer, Peter, Muller, David A., Schlom, Darrell G.

Volltext

Avoiding timescale bias in assessments of coastal wetland vertical change von Breithaupt, Joshua L., Smoak, Joseph M., Byrne, Robert H., Waters, Matthew N., Moyer, Ryan P., Sanders, Christian J.

Volltext

Statistical Emulation of Climate Model Projections Based on Precomputed GCM Runs von Castruccio, Stefano, McInerney, David J., Stein, Michael L., Crouch, Feifei Liu, Jacob, Robert L., Moyer, Elisabeth J.

Volltext

A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models von Chan-Penebre, Elayne, Kuplast, Kristy G, Majer, Christina R, Boriack-Sjodin, P Ann, Wigle, Tim J, Johnston, L Danielle, Rioux, Nathalie, Munchhof, Michael J, Jin, Lei, Jacques, Suzanne L, West, Kip A, Lingaraj, Trupti, Stickland, Kimberly, Ribich, Scott A, Raimondi, Alejandra, Scott, Margaret Porter, Waters, Nigel J, Pollock, Roy M, Smith, Jesse J, Barbash, Olena, Pappalardi, Melissa, Ho, Thau F, Nurse, Kelvin, Oza, Khyati P, Gallagher, Kathleen T, Kruger, Ryan, Moyer, Mikel P, Copeland, Robert A, Chesworth, Richard, Duncan, Kenneth W

Volltext

A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential von Bird, Gregory H., Patten, J. J., Zavadoski, William, Barucci, Nicole, Godes, Marina, Moyer, Benjamin M., Owen, Callum D., DaSilva-Jardine, Paul, Neuberg, Donna S., Bowen, Richard A., Davey, Robert A., Walensky, Loren D.

Volltext

Warfarin Genotyping Reduces Hospitalization Rates: Results From the MM-WES (Medco-Mayo Warfarin Effectiveness Study) von EPSTEIN, Robert S, MOYER, Thomas P, AUBERT, Ronald E, O'KANE, Dennis J, FANG XIA, VERBRUGGE, Robert R, GAGE, Brian F, TEAGARDEN, J. Russell

Volltext

A687V EZH2 is a gain-of-function mutation found in lymphoma patients von Majer, Christina R., Jin, Lei, Scott, Margaret Porter, Knutson, Sarah K., Kuntz, Kevin W., Keilhack, Heike, Smith, Jesse J., Moyer, Mikel P., Richon, Victoria M., Copeland, Robert A., Wigle, Tim J.

Volltext

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group von Lobera, Mercedes, Madauss, Kevin P, Pohlhaus, Denise T, Wright, Quentin G, Trocha, Mark, Schmidt, Darby R, Baloglu, Erkan, Trump, Ryan P, Head, Martha S, Hofmann, Glenn A, Murray-Thompson, Monique, Schwartz, Benjamin, Chakravorty, Subhas, Wu, Zining, Mander, Palwinder K, Kruidenier, Laurens, Reid, Robert A, Burkhart, William, Turunen, Brandon J, Rong, James X, Wagner, Craig, Moyer, Mary B, Wells, Carrow, Hong, Xuan, Moore, John T, Williams, Jon D, Soler, Dulce, Ghosh, Shomir, Nolan, Michael A

Volltext

Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy von Wermers, Robert A., Cooper, Kay, Razonable, Raymund R., Deziel, Paul J., Whitford, Gary M., Kremers, Walter K., Moyer, Thomas P.

Volltext

Lights, fluorescence, action-Influencing wound treatment plans including debridement of bacteria and biofilms von Jacob, Ashley, Jones, Laura M, Abdo, Raymond J, Cruz-Schiavone, Sebastian F, Skerker, Robert, Caputo, Wayne J, Krehbiel, Nathan, Moyer-Harris, Audrey K, McAtee, Alyssa, Baker, Isabel, Gray, Micaela D, Rennie, Monique Y

Volltext

Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666 von Duncan, Kenneth W, Rioux, Nathalie, Boriack-Sjodin, P. Ann, Munchhof, Michael J, Reiter, Lawrence A, Majer, Christina R, Jin, Lei, Johnston, L. Danielle, Chan-Penebre, Elayne, Kuplast, Kristy G, Porter Scott, Margaret, Pollock, Roy M, Waters, Nigel J, Smith, Jesse J, Moyer, Mikel P, Copeland, Robert A, Chesworth, Richard

Volltext